COLGATE PALMOLIVE CO
$90.76
+0.12%
Colgate-Palmolive raised its quarterly dividend to $0.53 from $0.52, marking its 63rd consecutive annual dividend increase and cementing its status as one of the most consistent dividend growers in the consumer staples sector. The board elected Christopher S. Boerner, CEO of Bristol-Myers Squibb, as a new director on March 12, 2026, adding healthcare sector expertise and strategic perspective. The stock trades at approximately $88.50 with a Buy consensus from 17 analysts and a $95.06 price target, though recent near-term underperformance reflects broader consumer staples sector pressure as tariff and inflation concerns weigh on global brand margins.